Cephalexin

CAS 23325-78-2 7 current records 19 historicalSmall Molecule

Who holds supplier records for Cephalexin? 7 organisations hold a current record for Cephalexin: an active US FDA Type II Drug Master File or a CEP. A further 19 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Italy (1), Netherlands (1), Brazil (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cephalexin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cephalexin

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cephalexin. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Cephalexin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Cephalexin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ACS DOBFAR S.P.A. TribianoIT
CEP 2025-569 - Rev 00
Cefalexin monohydrate, Enzymatic
Apr 2026—
ORCHID PHARMA LIMITED AlathurIN
CEP 2001-440 - Rev 05
Cefalexin monohydrate, Powder and compacted
Sept 2024Inspected Oct 2024
Poland
CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. DelftNL
CEP 1997-007 - Rev 08
Cefalexin monohydrate, Powder, compacted
Jun 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2005-001 - Rev 03
Cefalexin monohydrate
Dec 2023—
LUPIN LIMITED MumbaiIN
R1-CEP 2010-193 - Rev 01
Cefalexin monohydrate
May 2021—
ANTIBIÓTICOS DE LEÓN S.L.U LeónES
R1-CEP 2003-166 - Rev 02
Cefalexin monohydrate
Feb 2015—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (19)

Organisations whose Type II DMFs for Cephalexin are no longer active. These show a past filing, not current supply.

Show all 19 historical records
  • YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD
    Inactive DMF 23872 · filed Jun 2010
  • ZHEJIANG ANGLIKANG PHARMACEUTICAL CO LTD
    Inactive DMF 21842 · filed Jul 2008
  • India · Inactive DMF 19162, 13759 · filed Feb 2006
  • India · Inactive DMF 18361 · filed May 2005
  • LILLY RESEARCH LABORATORIES DIV ELI LILLY AND CO
    Inactive DMF 14920 · filed Jun 2000
  • JK DRUGS AND PHARMACEUTICALS LTD
    Inactive DMF 14266 · filed Jun 1999
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 13719 · filed Sept 1998
  • USA · Inactive DMF 13723 · filed Sept 1998
  • BIOCHEMIE SA
    Inactive DMF 13747 · filed Sept 1998
  • Taiwan · Inactive DMF 13781 · filed Sept 1998
  • YOSHITOMI PHARMACEUTICAL INDUSTRIES LTD
    Inactive DMF 13715 · filed Sept 1998
  • BENZEX LABORATORIES LTD
    Inactive DMF 13733 · filed Sept 1998
  • DISTA PRODUCTS CO DIV ELI LILLY AND CO
    Inactive DMF 13610 · filed Sept 1998
  • LILLY RESEARCH LABORATORIES
    Inactive DMF 13385 · filed Sept 1998
  • ISF
    Inactive DMF 13534 · filed Sept 1998
  • LARK
    Inactive DMF 13519 · filed Sept 1998
  • SQUIBB MFG
    Inactive DMF 13720 · filed Sept 1998
  • United States · Inactive DMF 6090 · filed Nov 1985
  • GLAXO LABORATORIES SA
    Inactive DMF 1820 · filed Nov 1971

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Cephalexin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200544).

Chemical identity

IUPAC name
(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate
Canonical SMILES
CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O.O
InChIKey
AVGYWQBCYZHHPN-CYJZLJNKSA-N
Synonyms
66873, Biocef, Cefalexin, Cefalexin monohydrate, Cefanex, Cephalexin, Cephalexin monohydrate, Ceporex, Keflet, Keflex, Kiflone, LY-66873

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cephalosporin Antibacterial
Chemical structure
Cephalosporins

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cephalexin?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Cephalexin: APITORIA PHARMA PRIVATE LTD (India), Lupin Limited (India), ACS DOBFAR SPA (Italy), CENTRIENT PHARMACEUTICALS NETHERLANDS BV (Netherlands), Orchid Pharma Limited (India), ANTIBIOTICOS (Brazil) and ANTIBIOTICOS DE LEON SLU (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cephalexin Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 32930, 17604), Lupin Limited (DMF 17277, 13752), ACS DOBFAR SPA (DMF 13612), CENTRIENT PHARMACEUTICALS NETHERLANDS BV (DMF 13210), Orchid Pharma Limited (DMF 15106) and ANTIBIOTICOS (DMF 13588, 13564). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cephalexin records mean?

19 organisations have only inactive Type II DMFs for Cephalexin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Cephalexin have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Cephalexin on the EDQM register, including ACS DOBFAR S.P.A. Tribiano (IT), ORCHID PHARMA LIMITED Alathur (IN), CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft (NL), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), LUPIN LIMITED Mumbai (IN) and ANTIBIÓTICOS DE LEÓN S.L.U León (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Cephalexin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cephalexin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.